학술논문
Phase IV multicenter study evaluating RWE and the safety of talazoparib in patients with locally advanced or metastatic negative HER2 breast cancer and a BRCA1/2 mutation (ViTAL) - Cohort 2: patients treated according to the EMA
Document Type
Journal
Author
Loirat, Delphine; de la Barre, Marie Duboys; Villanueva, Cristian; Mailliez, Audrey; Isambert, Nicolas; Moreau, Lionel; Jacquet, Emmanuelle; Spaeth, Dominique; Creisson, Anne; Jouannaud, Christelle; Legouffe, Eric; Delbado, Miguel; Deiana, Laura; Soibinet, Pauline; Hrab, Ioana; Grellety, Thomas; Dohollou, Nadine; Longo, Raffaele; Thery, Jean-Christophe; Fumet, Jean-david; Zineb, Sellam; Pujol, Pascal; de la Motte Rouge, thibault
Source
Subject
Language
English
ISSN
15387445